HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleolar volume in senile dementia.

Abstract
Treatment of patients suffering from senile dementia with meclofenoxate has been reported to result in an improvement in mental performance. Furthermore meclofenoxate reduces the amount of lipofuscin pigment in nerve cells. We have shown that, although nerve cells in a group of demented patients have decreased amounts of cytoplasmic RNA and reduced nucleolar volume, they contain no more pigment than do cells of a control group. It seems, therefore, unlikely that removal of lipofuscin, per se, has any bearing on this reported improvement in intellectual capability, nor is it implicated in the aetiology of senile dementia.
AuthorsD M Mann, K G Sinclair
JournalNeuropathology and applied neurobiology (Neuropathol Appl Neurobiol) 1978 Mar-Apr Vol. 4 Issue 2 Pg. 129-35 ISSN: 0305-1846 [Print] England
PMID355912 (Publication Type: Journal Article)
Chemical References
  • Lipofuscin
  • Pigments, Biological
  • RNA, Ribosomal
  • Meclofenoxate
Topics
  • Aged
  • Aging
  • Cell Nucleolus
  • Dementia (drug therapy, metabolism, pathology)
  • Female
  • Humans
  • Lipofuscin (analysis)
  • Male
  • Meclofenoxate (therapeutic use)
  • Pigments, Biological (analysis)
  • RNA, Ribosomal (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: